| CELCUITY INC. DL -,001 |
| USA |
| Gesundheit |
| US15102K1007 / A2JAAX |
| 7VR (Frankfurt) / CELC (NASDAQ) |
| FRA:7VR, ETR:7VR, 7VR:GR, NASDAQ:CELC |
| - |
| https://www.celcuity.com/ |
|
Celcuity Inc. is a clinical-stage biotechnology company focused on advancing oncology therapeutics and precision cancer diagnostics. The company develops innovative approaches to cancer treatment through its lead therapeutic candidate, gedatolisib, a..
>Volltext.. |
| 3770.46 Mio. EUR |
| 3715.38 Mio. EUR |
| - |
| -161.03 Mio. EUR |
| -166.65 Mio. EUR |
| -3.37 EUR |
| 279.44 Mio. EUR |
| 125.44 Mio. EUR |
| -149.03 Mio. EUR |
| 11.65 |
| - |
| -42.03% |
| - |
| - |
| - |
| - |
| CELCUITY |
| 13.06.26 |
|